购物车
全部删除
您的购物车当前为空
BCR-ABL-IN-2 is a BCR-ABL1 tyrosine kinase inhibitor (IC50s: 57 nM, 773 nM for ABL1 native and ABL1 T315I).

BCR-ABL-IN-2 is a BCR-ABL1 tyrosine kinase inhibitor (IC50s: 57 nM, 773 nM for ABL1 native and ABL1 T315I).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 16,940 | 6-8周 | |
| 50 mg | ¥ 22,260 | 6-8周 | |
| 100 mg | ¥ 30,100 | 6-8周 |
BCR-ABL-IN-2 相关产品
| 产品描述 | BCR-ABL-IN-2 is a BCR-ABL1 tyrosine kinase inhibitor (IC50s: 57 nM, 773 nM for ABL1 native and ABL1 T315I). |
| 靶点活性 | Abl-1 (native):57 nM, Abl-1 (T315I):773 nM |
| 体外活性 | BCR-ABL-IN-2 exhibits an IC50 of 57 nM for ABL1native and an IC50 of 773 nM for ABL1T315I [1]. Despite ABL, BCR-ABL-IN-2 can also inhibit KDR, BRaf, p38 kinase with IC50s of 1.8 μM, 0.23 μM, 6.3 nM, 43 nM, respectively [2]. |
| 分子量 | 502.39 |
| 分子式 | C24H25Cl2N5O3 |
| CAS No. | 897369-18-5 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容